Valuation Fuan Pharmaceutical (Group) Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-10-28			5-day change	1st Jan Change
3.610 ^CNY	-0.55%		-5.00%	-18.51%

10-26	Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-26	Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	5,865	6,091	4,283	5,211	5,306	5,270
Change	-	3.85%	-29.69%	21.67%	1.83%	-0.67%
Enterprise Value (EV) ¹	5,558	5,995	4,293	5,107	5,136	5,034
Change	-	7.87%	-28.39%	18.95%	0.56%	-1.97%
P/E	27.4x	-20.5x	21.2x	23.1x	18.6x	73.8x
PBR	1.43x	1.63x	1.09x	1.26x	1.21x	1.21x
PEG	-	0x	-0x	2x	0.7x	-1x
Capitalization / Revenue	2.48x	2.48x	1.77x	1.97x	2.22x	3.03x
EV / Revenue	2.35x	2.44x	1.77x	1.93x	2.15x	2.9x
EV / EBITDA	16.8x	18.6x	15.5x	13x	11.5x	19.3x
EV / EBIT	31.6x	40.6x	45.6x	27.7x	20.7x	88.8x
EV / FCF	119x	-58.5x	-66.5x	52x	-137x	39x
FCF Yield	0.84%	-1.71%	-1.5%	1.92%	-0.73%	2.57%
Dividend per Share ²	0.05	-	0.05	0.05	0.05	0.07
Rate of return	1.01%	-	1.39%	1.14%	1.12%	1.58%
EPS ²	0.18	-0.25	0.17	0.19	0.24	0.06
Distribution rate	27.8%	-	29.4%	26.3%	20.8%	117%
Net sales ¹	2,368	2,453	2,422	2,648	2,391	1,738
EBITDA ¹	331.7	321.7	277.8	392.6	445.6	260.5
EBIT ¹	176.1	147.6	94.18	184.5	248.6	56.69
Net income ¹	209.4	-296.9	204.6	231.9	279.8	77
Net Debt ¹	-307.4	-95.96	10.45	-104	-170.5	-236.2
Reference price ²	4.930	5.120	3.600	4.380	4.460	4.430
Nbr of stocks (in thousands)	1,189,712	1,189,712	1,189,712	1,189,712	1,189,712	1,189,712
Announcement Date	3/30/21	4/25/22	3/30/23	4/24/24	4/23/25	4/26/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FUAN PHARMACEUTICAL (GROUP) CO., LTD.	-	-	-	-	644M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	403.78B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%